LitCovid_Glycan-Motif-Structure  

Documents (59,168) JSON TSV

source DB source ID text size updated at # proj. # Ann. updated_at
PubMed 33125711 Unfractionated heparin inhibits live wild-type SARS-CoV-2 cell infectivity at therapeutically releva 1.82 KB 2020-11-19 19 20 2021-01-20
PubMed 33041824 Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A 1.35 KB 2020-11-19 20 18 2021-01-20
PubMed 32970989 SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. We show that SARS-CoV-2 spike pro 1.09 KB 2020-11-19 34 16 2021-01-20
PubMed 32542212 Using heparin molecules to manage COVID-2019. The coronavirus disease 2019 (COVID-19) pandemic is be 1.05 KB 2020-06-26 14 12 2021-01-20
PubMed 33134948 A Method to Improve Continuous Renal Replacement Therapy Circuit Survival Time in Critically Ill Cor 1.58 KB 2020-11-19 19 10 2021-01-20
PubMed 33127399 COVID-19 and climatic factors: A global analysis. BACKGROUND: It is unknown if COVID-19 will exhibit 1.81 KB 2020-11-19 19 8 2021-01-20
PubMed 33116032 Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome. 1.61 KB 2020-11-19 19 8 2021-01-20
PubMed 33040469 Elevated fasting blood glucose within the first week of hospitalization was associated with progress 1.09 KB 2020-11-19 19 7 2021-01-20
PubMed 33123093 The Impact of COVID-19 on Blood Glucose: A Systematic Review and Meta-Analysis. Background: Diabetes 1.7 KB 2020-11-19 19 7 2021-01-20
PubMed 32838169 Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials. The following systemat 1.58 KB 2020-09-23 20 6 2021-01-20